APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Analytical Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmaceutical Analytical Testing Market Analysis and Forecast 2026-2032

1 January 2026196 pages

Choose your research edition.

Industry ResearchPharmaceutical Analytical Testing Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Analytical Testing Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Analytical Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Analytical Testing Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Analytical Testing Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Pharmaceutical Analytical Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pharmaceutical Analytical Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmaceutical Analytical Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmaceutical Analytical Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmaceutical Analytical Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pharmaceutical Analytical Testing include Laboratory Testing, Eurofins Scientific, SGS SA, Intertek Phamaceutical Services, West Pharmaceutical Services, Toxikon, Pace Analytical Services, Boston Analytical and Steris, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pharmaceutical Analytical Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmaceutical Analytical Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmaceutical Analytical Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical Analytical Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical Analytical Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical Analytical Testing revenue, projected growth trends, production technology, application and end-user industry.

Pharmaceutical Analytical Testing Segment by Company

Laboratory Testing

Eurofins Scientific

SGS SA

Intertek Phamaceutical Services

West Pharmaceutical Services

Toxikon

Pace Analytical Services

Boston Analytical

Steris

Catalent

Charles River Laboratories

Merck

Solvias

Pharmaceutical Analytical Testing Segment by Type

Bioanalytical Testing

Method Development & Validation

Stability Testing

Drug Substances Testing

Pharmaceutical Analytical Testing Segment by Application

Laboratory and Research Institutions

Pharmaceutical Center

Other

Pharmaceutical Analytical Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Analytical Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Analytical Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Analytical Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pharmaceutical Analytical Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pharmaceutical Analytical Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Analytical Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Analytical Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Bioanalytical Testing Major Player Table 3. Method Development & Validation Major Player Table 4. Stability Testing Major Player Table 5. Drug Substances Testing Major Player Table 6. Global Pharmaceutical Analytical Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Laboratory and Research Institutions Major Player Table 8. Pharmaceutical Center Major Player Table 9. Other Major Player Table 10. Pharmaceutical Analytical Testing Industry Trends Table 11. Pharmaceutical Analytical Testing Industry Drivers Table 12. Pharmaceutical Analytical Testing Industry Opportunities and Challenges Table 13. Pharmaceutical Analytical Testing Industry Restraints Table 14. Global Pharmaceutical Analytical Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Pharmaceutical Analytical Testing Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Pharmaceutical Analytical Testing Market Share by Region (2021-2026) Table 17. Global Pharmaceutical Analytical Testing Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Pharmaceutical Analytical Testing Market Share by Region (2027-2032) Table 19. Global Pharmaceutical Analytical Testing Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Pharmaceutical Analytical Testing Revenue Market Share by Players (2021-2026) Table 21. Global Pharmaceutical Analytical Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Pharmaceutical Analytical Testing Key Players Headquarters & Area Served Table 23. Global Pharmaceutical Analytical Testing Players, Product Type & Application Table 24. Global Pharmaceutical Analytical Testing Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Pharmaceutical Analytical Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Pharmaceutical Analytical Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pharmaceutical Analytical Testing Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Pharmaceutical Analytical Testing Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Pharmaceutical Analytical Testing Revenue Market Share by Type (2021-2026) Table 31. Global Pharmaceutical Analytical Testing Revenue Market Share by Type (2027-2032) Table 32. Global Pharmaceutical Analytical Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pharmaceutical Analytical Testing Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Pharmaceutical Analytical Testing Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Pharmaceutical Analytical Testing Revenue Market Share by Application (2021-2026) Table 36. Global Pharmaceutical Analytical Testing Revenue Market Share by Application (2027-2032) Table 37. Laboratory Testing Company Information Table 38. Laboratory Testing Business Overview Table 39. Laboratory Testing Pharmaceutical Analytical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Laboratory Testing Pharmaceutical Analytical Testing Product Portfolio Table 41. Laboratory Testing Recent Development Table 42. Eurofins Scientific Company Information Table 43. Eurofins Scientific Business Overview Table 44. Eurofins Scientific Pharmaceutical Analytical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Eurofins Scientific Pharmaceutical Analytical Testing Product Portfolio Table 46. Eurofins Scientific Recent Development Table 47. SGS SA Company Information Table 48. SGS SA Business Overview Table 49. SGS SA Pharmaceutical Analytical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. SGS SA Pharmaceutical Analytical Testing Product Portfolio Table 51. SGS SA Recent Development Table 52. Intertek Phamaceutical Services Company Information Table 53. Intertek Phamaceutical Services Business Overview Table 54. Intertek Phamaceutical Services Pharmaceutical Analytical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Intertek Phamaceutical Services Pharmaceutical Analytical Testing Product Portfolio Table 56. Intertek Phamaceutical Services Recent Development Table 57. West Pharmaceutical Services Company Information Table 58. West Pharmaceutical Services Business Overview Table 59. West Pharmaceutical Services Pharmaceutical Analytical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. West Pharmaceutical Services Pharmaceutical Analytical Testing Product Portfolio Table 61. West Pharmaceutical Services Recent Development Table 62. Toxikon Company Information Table 63. Toxikon Business Overview Table 64. Toxikon Pharmaceutical Analytical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Toxikon Pharmaceutical Analytical Testing Product Portfolio Table 66. Toxikon Recent Development Table 67. Pace Analytical Services Company Information Table 68. Pace Analytical Services Business Overview Table 69. Pace Analytical Services Pharmaceutical Analytical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Pace Analytical Services Pharmaceutical Analytical Testing Product Portfolio Table 71. Pace Analytical Services Recent Development Table 72. Boston Analytical Company Information Table 73. Boston Analytical Business Overview Table 74. Boston Analytical Pharmaceutical Analytical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Boston Analytical Pharmaceutical Analytical Testing Product Portfolio Table 76. Boston Analytical Recent Development Table 77. Steris Company Information Table 78. Steris Business Overview Table 79. Steris Pharmaceutical Analytical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Steris Pharmaceutical Analytical Testing Product Portfolio Table 81. Steris Recent Development Table 82. Catalent Company Information Table 83. Catalent Business Overview Table 84. Catalent Pharmaceutical Analytical Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Catalent Pharmaceutical Analytical Testing Product Portfolio Table 86. Catalent Recent Development Table 87. Charles River Laboratories Company Information Table 88. Charles River Laboratories Business Overview Table 89. Charles River Laboratories Pharmaceutical Analytical Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Charles River Laboratories Pharmaceutical Analytical Testing Product Portfolio Table 91. Charles River Laboratories Recent Development Table 92. Merck Company Information Table 93. Merck Business Overview Table 94. Merck Pharmaceutical Analytical Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Merck Pharmaceutical Analytical Testing Product Portfolio Table 96. Merck Recent Development Table 97. Solvias Company Information Table 98. Solvias Business Overview Table 99. Solvias Pharmaceutical Analytical Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Solvias Pharmaceutical Analytical Testing Product Portfolio Table 101. Solvias Recent Development Table 102. North America Pharmaceutical Analytical Testing Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Pharmaceutical Analytical Testing Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Pharmaceutical Analytical Testing Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Pharmaceutical Analytical Testing Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Pharmaceutical Analytical Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. North America Pharmaceutical Analytical Testing Revenue by Country (2021-2026) & (US$ Million) Table 108. North America Pharmaceutical Analytical Testing Revenue by Country (US$ Million) & (2027-2032) Table 109. Europe Pharmaceutical Analytical Testing Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Pharmaceutical Analytical Testing Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Pharmaceutical Analytical Testing Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Pharmaceutical Analytical Testing Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Pharmaceutical Analytical Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe Pharmaceutical Analytical Testing Revenue by Country (2021-2026) & (US$ Million) Table 115. Europe Pharmaceutical Analytical Testing Revenue by Country (US$ Million) & (2027-2032) Table 116. China Pharmaceutical Analytical Testing Revenue by Type (2021-2026) & (US$ Million) Table 117. China Pharmaceutical Analytical Testing Revenue by Type (2027-2032) & (US$ Million) Table 118. China Pharmaceutical Analytical Testing Revenue by Application (2021-2026) & (US$ Million) Table 119. China Pharmaceutical Analytical Testing Revenue by Application (2027-2032) & (US$ Million) Table 120. Asia Pharmaceutical Analytical Testing Revenue by Type (2021-2026) & (US$ Million) Table 121. Asia Pharmaceutical Analytical Testing Revenue by Type (2027-2032) & (US$ Million) Table 122. Asia Pharmaceutical Analytical Testing Revenue by Application (2021-2026) & (US$ Million) Table 123. Asia Pharmaceutical Analytical Testing Revenue by Application (2027-2032) & (US$ Million) Table 124. Asia Pharmaceutical Analytical Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Asia Pharmaceutical Analytical Testing Revenue by Region (US$ Million) & (2021-2026) Table 126. Asia Pharmaceutical Analytical Testing Revenue by Region (US$ Million) & (2027-2032) Table 127. SAMEA Pharmaceutical Analytical Testing Revenue by Type (2021-2026) & (US$ Million) Table 128. SAMEA Pharmaceutical Analytical Testing Revenue by Type (2027-2032) & (US$ Million) Table 129. SAMEA Pharmaceutical Analytical Testing Revenue by Application (2021-2026) & (US$ Million) Table 130. SAMEA Pharmaceutical Analytical Testing Revenue by Application (2027-2032) & (US$ Million) Table 131. SAMEA Pharmaceutical Analytical Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. SAMEA Pharmaceutical Analytical Testing Revenue by Country (2021-2026) & (US$ Million) Table 133. SAMEA Pharmaceutical Analytical Testing Revenue by Country (US$ Million) & (2027-2032) Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Pharmaceutical Analytical Testing Image Figure 2. Global Pharmaceutical Analytical Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Analytical Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Bioanalytical Testing Image Figure 5. Method Development & Validation Image Figure 6. Stability Testing Image Figure 7. Drug Substances Testing Image Figure 8. Global Pharmaceutical Analytical Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Pharmaceutical Analytical Testing Market Size Share 2021 VS 2025 VS 2032 Figure 10. Laboratory and Research Institutions Image Figure 11. Pharmaceutical Center Image Figure 12. Other Image Figure 13. Global Pharmaceutical Analytical Testing Market Size (US$ Million) & (2021-2032) Figure 14. Global Pharmaceutical Analytical Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Pharmaceutical Analytical Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Pharmaceutical Analytical Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Pharmaceutical Analytical Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pharmaceutical Analytical Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Pharmaceutical Analytical Testing Revenue Market Share by Type (2021-2032) Figure 21. Global Pharmaceutical Analytical Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Pharmaceutical Analytical Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Pharmaceutical Analytical Testing Revenue Market Share by Application (2021-2032) Figure 24. North America Pharmaceutical Analytical Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Pharmaceutical Analytical Testing Revenue Share by Type (2021-2032) Figure 26. North America Pharmaceutical Analytical Testing Revenue Share by Application (2021-2032) Figure 27. North America Pharmaceutical Analytical Testing Revenue Share by Country (2021-2032) Figure 28. United States Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Pharmaceutical Analytical Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Pharmaceutical Analytical Testing Revenue Share by Type (2021-2032) Figure 33. Europe Pharmaceutical Analytical Testing Revenue Share by Application (2021-2032) Figure 34. Europe Pharmaceutical Analytical Testing Revenue Share by Country (2021-2032) Figure 35. Germany Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Pharmaceutical Analytical Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Pharmaceutical Analytical Testing Revenue Share by Type (2021-2032) Figure 45. China Pharmaceutical Analytical Testing Revenue Share by Application (2021-2032) Figure 46. Asia Pharmaceutical Analytical Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Pharmaceutical Analytical Testing Revenue Share by Type (2021-2032) Figure 48. Asia Pharmaceutical Analytical Testing Revenue Share by Application (2021-2032) Figure 49. Asia Pharmaceutical Analytical Testing Revenue Share by Region (2021-2032) Figure 50. Japan Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Pharmaceutical Analytical Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Pharmaceutical Analytical Testing Revenue Share by Type (2021-2032) Figure 58. SAMEA Pharmaceutical Analytical Testing Revenue Share by Application (2021-2032) Figure 59. SAMEA Pharmaceutical Analytical Testing Revenue Share by Country (2021-2032) Figure 60. Brazil Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Pharmaceutical Analytical Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Bioanalytical Testing
  • Method Development & Validation
  • Stability Testing
  • Drug Substances Testing
Applications
  • Laboratory and Research Institutions
  • Pharmaceutical Center
  • Other
Companies covered
  • Laboratory Testing
  • Eurofins Scientific
  • SGS SA
  • Intertek Phamaceutical Services
  • West Pharmaceutical Services
  • Toxikon
  • Pace Analytical Services
  • Boston Analytical
  • Steris
  • Catalent
  • Charles River Laboratories
  • Merck
  • Solvias

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmaceutical Analytical Testing Market by Type
  3. 1.2.1 Global Pharmaceutical Analytical Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Bioanalytical Testing
  5. 1.2.3 Method Development & Validation
  6. 1.2.4 Stability Testing
  7. 1.2.5 Drug Substances Testing
  8. 1.3 Pharmaceutical Analytical Testing Market by Application
  9. 1.3.1 Global Pharmaceutical Analytical Testing Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Laboratory and Research Institutions
  11. 1.3.3 Pharmaceutical Center
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Pharmaceutical Analytical Testing Market Dynamics
  1. 2.1 Pharmaceutical Analytical Testing Industry Trends
  2. 2.2 Pharmaceutical Analytical Testing Industry Drivers
  3. 2.3 Pharmaceutical Analytical Testing Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Analytical Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pharmaceutical Analytical Testing Market Perspective (2021-2032)
  2. 3.2 Global Pharmaceutical Analytical Testing Growth Trends by Region
  3. 3.2.1 Global Pharmaceutical Analytical Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmaceutical Analytical Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Pharmaceutical Analytical Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pharmaceutical Analytical Testing Revenue by Players
  2. 4.1.1 Global Pharmaceutical Analytical Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Pharmaceutical Analytical Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pharmaceutical Analytical Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmaceutical Analytical Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pharmaceutical Analytical Testing Key Players Headquarters & Area Served
  7. 4.4 Global Pharmaceutical Analytical Testing Players, Product Type & Application
  8. 4.5 Global Pharmaceutical Analytical Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pharmaceutical Analytical Testing Market CR5 and HHI
  11. 4.6.3 2025 Pharmaceutical Analytical Testing Tier 1, Tier 2, and Tier 3
5 Pharmaceutical Analytical Testing Market Size by Type
  1. 5.1 Global Pharmaceutical Analytical Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical Analytical Testing Revenue by Type (2021-2032)
  3. 5.3 Global Pharmaceutical Analytical Testing Revenue Market Share by Type (2021-2032)
6 Pharmaceutical Analytical Testing Market Size by Application
  1. 6.1 Global Pharmaceutical Analytical Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pharmaceutical Analytical Testing Revenue by Application (2021-2032)
  3. 6.3 Global Pharmaceutical Analytical Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Laboratory Testing
  2. 7.1.1 Laboratory Testing Company Information
  3. 7.1.2 Laboratory Testing Business Overview
  4. 7.1.3 Laboratory Testing Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Laboratory Testing Pharmaceutical Analytical Testing Product Portfolio
  6. 7.1.5 Laboratory Testing Recent Developments
  7. 7.2 Eurofins Scientific
  8. 7.2.1 Eurofins Scientific Company Information
  9. 7.2.2 Eurofins Scientific Business Overview
  10. 7.2.3 Eurofins Scientific Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Eurofins Scientific Pharmaceutical Analytical Testing Product Portfolio
  12. 7.2.5 Eurofins Scientific Recent Developments
  13. 7.3 SGS SA
  14. 7.3.1 SGS SA Company Information
  15. 7.3.2 SGS SA Business Overview
  16. 7.3.3 SGS SA Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 SGS SA Pharmaceutical Analytical Testing Product Portfolio
  18. 7.3.5 SGS SA Recent Developments
  19. 7.4 Intertek Phamaceutical Services
  20. 7.4.1 Intertek Phamaceutical Services Company Information
  21. 7.4.2 Intertek Phamaceutical Services Business Overview
  22. 7.4.3 Intertek Phamaceutical Services Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Intertek Phamaceutical Services Pharmaceutical Analytical Testing Product Portfolio
  24. 7.4.5 Intertek Phamaceutical Services Recent Developments
  25. 7.5 West Pharmaceutical Services
  26. 7.5.1 West Pharmaceutical Services Company Information
  27. 7.5.2 West Pharmaceutical Services Business Overview
  28. 7.5.3 West Pharmaceutical Services Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 West Pharmaceutical Services Pharmaceutical Analytical Testing Product Portfolio
  30. 7.5.5 West Pharmaceutical Services Recent Developments
  31. 7.6 Toxikon
  32. 7.6.1 Toxikon Company Information
  33. 7.6.2 Toxikon Business Overview
  34. 7.6.3 Toxikon Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Toxikon Pharmaceutical Analytical Testing Product Portfolio
  36. 7.6.5 Toxikon Recent Developments
  37. 7.7 Pace Analytical Services
  38. 7.7.1 Pace Analytical Services Company Information
  39. 7.7.2 Pace Analytical Services Business Overview
  40. 7.7.3 Pace Analytical Services Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Pace Analytical Services Pharmaceutical Analytical Testing Product Portfolio
  42. 7.7.5 Pace Analytical Services Recent Developments
  43. 7.8 Boston Analytical
  44. 7.8.1 Boston Analytical Company Information
  45. 7.8.2 Boston Analytical Business Overview
  46. 7.8.3 Boston Analytical Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Boston Analytical Pharmaceutical Analytical Testing Product Portfolio
  48. 7.8.5 Boston Analytical Recent Developments
  49. 7.9 Steris
  50. 7.9.1 Steris Company Information
  51. 7.9.2 Steris Business Overview
  52. 7.9.3 Steris Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Steris Pharmaceutical Analytical Testing Product Portfolio
  54. 7.9.5 Steris Recent Developments
  55. 7.10 Catalent
  56. 7.10.1 Catalent Company Information
  57. 7.10.2 Catalent Business Overview
  58. 7.10.3 Catalent Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Catalent Pharmaceutical Analytical Testing Product Portfolio
  60. 7.10.5 Catalent Recent Developments
  61. 7.11 Charles River Laboratories
  62. 7.11.1 Charles River Laboratories Company Information
  63. 7.11.2 Charles River Laboratories Business Overview
  64. 7.11.3 Charles River Laboratories Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Charles River Laboratories Pharmaceutical Analytical Testing Product Portfolio
  66. 7.11.5 Charles River Laboratories Recent Developments
  67. 7.12 Merck
  68. 7.12.1 Merck Company Information
  69. 7.12.2 Merck Business Overview
  70. 7.12.3 Merck Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Merck Pharmaceutical Analytical Testing Product Portfolio
  72. 7.12.5 Merck Recent Developments
  73. 7.13 Solvias
  74. 7.13.1 Solvias Company Information
  75. 7.13.2 Solvias Business Overview
  76. 7.13.3 Solvias Pharmaceutical Analytical Testing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Solvias Pharmaceutical Analytical Testing Product Portfolio
  78. 7.13.5 Solvias Recent Developments
8 North America
  1. 8.1 North America Pharmaceutical Analytical Testing Revenue (2021-2032)
  2. 8.2 North America Pharmaceutical Analytical Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Pharmaceutical Analytical Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Pharmaceutical Analytical Testing Revenue by Type (2027-2032)
  5. 8.3 North America Pharmaceutical Analytical Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Pharmaceutical Analytical Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Pharmaceutical Analytical Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Pharmaceutical Analytical Testing Revenue by Application (2027-2032)
  9. 8.5 North America Pharmaceutical Analytical Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Pharmaceutical Analytical Testing Revenue by Country
  11. 8.6.1 North America Pharmaceutical Analytical Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pharmaceutical Analytical Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Pharmaceutical Analytical Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pharmaceutical Analytical Testing Revenue (2021-2032)
  2. 9.2 Europe Pharmaceutical Analytical Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pharmaceutical Analytical Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pharmaceutical Analytical Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Pharmaceutical Analytical Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pharmaceutical Analytical Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pharmaceutical Analytical Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pharmaceutical Analytical Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Pharmaceutical Analytical Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pharmaceutical Analytical Testing Revenue by Country
  11. 9.6.1 Europe Pharmaceutical Analytical Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pharmaceutical Analytical Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pharmaceutical Analytical Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pharmaceutical Analytical Testing Revenue (2021-2032)
  2. 10.2 China Pharmaceutical Analytical Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Pharmaceutical Analytical Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Pharmaceutical Analytical Testing Revenue by Type (2027-2032)
  5. 10.3 China Pharmaceutical Analytical Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Pharmaceutical Analytical Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Pharmaceutical Analytical Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Pharmaceutical Analytical Testing Revenue by Application (2027-2032)
  9. 10.5 China Pharmaceutical Analytical Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmaceutical Analytical Testing Revenue (2021-2032)
  2. 11.2 Asia Pharmaceutical Analytical Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pharmaceutical Analytical Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pharmaceutical Analytical Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Pharmaceutical Analytical Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pharmaceutical Analytical Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pharmaceutical Analytical Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pharmaceutical Analytical Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Pharmaceutical Analytical Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pharmaceutical Analytical Testing Revenue by Country
  11. 11.6.1 Asia Pharmaceutical Analytical Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pharmaceutical Analytical Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pharmaceutical Analytical Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmaceutical Analytical Testing Revenue (2021-2032)
  2. 12.2 SAMEA Pharmaceutical Analytical Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pharmaceutical Analytical Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pharmaceutical Analytical Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pharmaceutical Analytical Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pharmaceutical Analytical Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pharmaceutical Analytical Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pharmaceutical Analytical Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pharmaceutical Analytical Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pharmaceutical Analytical Testing Revenue by Country
  11. 12.6.1 SAMEA Pharmaceutical Analytical Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pharmaceutical Analytical Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pharmaceutical Analytical Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst